ARNTL2-AS1
ARNTL2-AS1: The Intriguing Long Non-Coding RNA
Introduction
ARNTL2-AS1 is a newly discovered long non-coding RNA (lncRNA) that has garnered significant attention due to its involvement in various biological processes and its association with several diseases. LncRNAs are a class of RNA molecules that do not code for proteins but play crucial regulatory roles in gene expression. Here, we delve into the world of ARNTL2-AS1, exploring its functions, associated diseases, and the latest research advancements.
Description
ARNTL2-AS1 is a 5,251-nucleotide lncRNA located on chromosome 3q21.3. It is antisense to the adjacent ARNTL2 gene, which encodes the aryl hydrocarbon receptor nuclear translocator-like 2 protein. ARNTL2-AS1 is highly conserved across species, indicating its functional importance.
Associated Diseases
ARNTL2-AS1 has been implicated in a range of diseases, including:
- Cirrhosis: ARNTL2-AS1 downregulation has been observed in patients with liver cirrhosis. It promotes hepatic cell death and inflammation, contributing to disease progression.
- Cardiovascular disease: ARNTL2-AS1 regulates endothelial cell function and angiogenesis. Its dysregulation can lead to vascular dysfunction and increased risk of heart disease and stroke.
- Neurological disorders: ARNTL2-AS1 has been found to be dysregulated in neurodegenerative diseases such as Alzheimer's and Parkinson's. It affects neuronal survival and synaptic plasticity.
Did you Know ?
A recent study reported that ARNTL2-AS1 expression is significantly decreased in the blood of patients with acute myocardial infarction (heart attack). This suggests that ARNTL2-AS1 may serve as a potential biomarker for early diagnosis and prognosis of cardiovascular events.
